(Q38462668)

3 September 2017

1 reference

title

Immunology of protection from Ebola virus infection (English)

1 reference

3 September 2017

Orthoebolavirus zairense

0 references

6

Nelson L Michael

1 reference

3 September 2017

8

Marion F Gruber

1 reference

3 September 2017

1

Philip R Krause

1 reference

3 September 2017

Paula R Bryant

2

1 reference

3 September 2017

Thomas Clark

3

1 reference

3 September 2017

Walla Dempsey

4

1 reference

3 September 2017

Erik Henchal

5

1 reference

3 September 2017

Jason A Regules

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Science Translational Medicine

3 September 2017

1 reference

3 September 2017

7

1 reference

3 September 2017

286

1 reference

3 September 2017

286ps11

1 reference

West African Ebola epidemic after one year--slowing but not yet under control

3 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

A race for an Ebola vaccine: promises and obstacles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Structures of protective antibodies reveal sites of vulnerability on Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

The multiple roles of sGP in Ebola pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Caring for critically ill patients with ebola virus disease. Perspectives from West Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

The Ebola Epidemic. High hopes for Guinean vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAA8202

10.1126/SCITRANSLMED.AAA8202

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference